Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Dementia 2020

About Conference


Neuroscience is the logical investigation of the sensory system. It is a multidisciplinary part of science that joins physiology, life structures, atomic science, Dementia, formative science, cytology, numerical displaying and brain science to comprehend the central and eminent properties of neurons and neural circuits. Dementia is a progressive and largely irreversible clinical syndrome characterised by a widespread impairment of mental function

Dementia 2020 is a World’s leading Scientific Conference which brings all the well distinguished academics together in the field of professionals, Phycology, academic scientists, professors to exchange their ideas about research state and technologies. Most of the Neurologists, Neuro-physicians, Critical Care Specialists, researchers and scientists will take part in this Conference. Papers will be presented in the form of symposia, plenary sessions & posters including the scientific and clinical material that was carefully selected by the Review Committee. The Conference helps in providing the ideal forum to stimulate establish collaborations & ideas.

Sessions/Tracks

Track 1: Dementia

Dementia is not a specific disease. It's an overall term that explains a vast range of complications associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform daily activities. Alzheimer's disease, vascular dementia, which occurs after a stroke, is the second most common dementia type.

  • Dementia With Lewy Bodies
  • Mixed dementia
  • Creutzfeldt–Jakob Disease
  • Parkinson’s Disease
  • Mild cognitive impairment
  • Frontotemporal dementia
  • Normal pressure hydrocephalus
  • Signs and symptoms of dementia

Dementia Conference 2020 | Mental Health Conference | Psychology ConferenceVascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference | Clinical Dementia ConferenceMental Health Conference 2020 | Zagreb Croatia Dementia Conference | Dementia Nursing Conference

Track 2: Alzheimer ’s Disease

Alzheimer's disease is the most common type of dementia, a general term of memory loss and other cognitive abilities severe enough to interfere with everyday life. Alzheimer's disease falls under for 60 to 80 percent of dementia cases.  Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of population with Alzheimer's are 60 and older. But Alzheimer's is not just a disease of old age people.

  • Risk Factors of Alzheimer’s
  • Diagnosis of Alzheimer’s
  • Treatments of Alzheimer’s
  • Clinical Studies of Alzheimer’s
  • Alzheimer’s disease Pathophysiology and Disease Mechanisms

Alzheimer’s Conference 2020 | Neuro Conference 2020 | Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020 | Zagreb Croatia Dementia Conference | Dementia Nursing Conference | Dementia Conference 2020 | Mental Health Conference | Psychology ConferenceVascular Dementia Conference

Track 3: Dementia and Ageing

Ageing: Unable to remember a conversation or event that took place a year ago, Unable to remember the name of an acquaintance, Forgetting things and events frequently, Occasionally have difficulty pronouncing words, You are worried about your memory but your relatives are not.

Dementia: Unable to recall details of very recent situations or conversations, not recognizing or knowing the names of members of family, Forgetting things more frequently, Frequent pauses and substitutions while finding suitable words to speak.

  • Neuro-anatomical changes in Ageing
  • Risk factors of Cognitive decline
  • Granulovacuolar Degeneration
  • Changes in Cerebral Cortical microvasculature
  • Advances of research in Ageing and Dementia

Dementia Nursing Conference | Alzheimer’s Conference 2020 | Neuro Conference 2020 | Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020 | Zagreb Croatia Dementia Conference | Dementia Nursing Conference | Dementia Conference 2020

Track 4: Vascular Dementia

Vascular dementia occurs when vessels which are supplying blood to the brain gets blocked or become narrowed. Strokes happens when the supply of blood which carry oxygen to the brain will suddenly obstruct. However, not all members with stroke will develop vascular dementia.

  • Vascular Dementia Prognosis
  • Young onset Dementia
  • Multi-infarct Dementia
  • Mixed Dementia
  • Parkinson Dementia
  • Advances in Vascular Dementia therapy

Vascular Dementia Conference | Brain Disorders Conference | Clinical Dementia Conference | Anxiety and Depression Conference | Dementia Nursing Conference | Alzheimer’s Conference 2020 | Neuro Conference 2020 | Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication was a specialty that targets on health care and wellness of older people. It aims to build health by diagnosing and treating diseases and other disabilities in older adults. There’s no set of age that patients are also underneath the care of a specialist or geriatric.

  • Delirium
  • Mild and Major Neurocognitive Disorder

Cognitive Disorder Conference | Dementia Nursing Conference | Alzheimer’s Conference 2020 | Neuro Conference 2020 | Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020 | Vascular Dementia Conference | Alzheimer’s Conference | Clinical Dementia Conference | Neurology Conference

Track 6: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease for pre-clinical and clinical translations. Dementia is a clinical syndrome possessing abnormal degree of loss of memeory and impaired ability to rollback situations from the past often characterized by Alzheimer's disease.

  • Neurobehavioral Toxicology Testing
  • Pre-clinical testing and Clinical translation
  • Protein-protein interactions
  • Genetics of translational models
  • Animal models of human cognitive aging

Clinical Dementia Conference | Neurology Conference | Cognitive Disorder Conference | Dementia Nursing Conference | Alzheimer’s Conference 2020 |  Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020 | |Vascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference 

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyper phosphorylated and cleaved forms of the microtubule-associated protein tau.

  • Amyloid Imaging
  • Amyloid Immunotherapy
  • FDG-PET

Alzheimer’s Conference 2020 | Neuro Conference 2020 | Zagreb Dementia Conference | Dementia Conference | Mental Health Conference 2020 | Vascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference | Clinical Dementia Conference | Cognitive Disorder Conference | Neurology Conference

Track 8: Dementia Care Management

The gradual increasing of vascular dementia patients prompts both approach, monetary and health care association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

  • Advances in Dementia Care Management
  • Dementia Care Management Program
  • Under nutrition and obesity in dementia
  • Advance care planning

Mental Health Conference 2020 | Vascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference | Clinical Dementia ConferenceNeuro Conference 2020 | Zagreb Dementia Conference | Zagreb Croatia Dementia Conference | Dementia Nursing Conference

Track 9: Dementia Nursing

Individuals with vascular dementia having different mental element shortfalls that include every memory obstacle, that holds the adaptability to create new data or review data already learned, and one or extra of the ensuring some side effects like apraxia, agnosia, or official brokenness to an extent that the mental element shortages noticeably affect social or action working with a major decrease in past abilities.

  • Dementia Nursing care plan
  • Music therapy in Dementia
  • Dementia Physiotherapy
  • Clinical features of dementia
  • Dementia Therapeutic intervention

Psychology Conference | Vascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference | Clinical Dementia Conference | Vascular Dementia Conference | Alzheimer’s ConferenceClinical Dementia Conference | Neurology Conference | Cognitive Disorder Conference | Mental Health Conference 2020

Track 10: Recent Advancement in Treating Dementia

Early Detection and exact analysis are critical, as vascular dementia is at any rate halfway preventable. Ischemic changes in the cerebrum are hardly irreversible, however the particular patient with vascular dementia can experience times of solidness or even mild changes. Since stroke is a basic part of vascular dementia, the foremost aspect is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus.

  • Primary mental health care and nursing
  • Psychopharmacological treatment
  • Advanced drugs for dementia
  • Cognitive behavioral therapy
  • Family therapy in nursing

Dementia Conference 2020 | Mental Health Conference | Psychology Conference | Vascular Dementia Conference | Alzheimer’s Conference | Brain Disorders Conference | Clinical Dementia Conference | Neurology Conference | Vascular Dementia Conference | Alzheimer’s Conference

Market Report

Dementia is a form of disease that affects the functioning of the brain resulting in decline in memory or other thinking skills. Alzheimer’s disease is the most common and largest form of dementia (in over 60% cases), which is observed among people aged 65 years and above. Accumulation of a protein called beta amyloid, in the spaces between nerve cells due to genetic mutation is a major cause of dementia. Although dementia disease is not treatable, symptomatic treatment is followed in all cases. Research is being carried out to develop treatment centered on the role of beta-amyloid in dementia.

The global dementia drugs market estimated to be valued at US$ 13,900.0 million in 2017 and is expected to witness a CAGR of 8.4% over the forecast period (2018–2026).

Past Conference Report

Vascular Dementia 2019

The International conference was targetted on the theme, “Decoding Dementia & Alzheimer's  disease” and facilitated by the ConferenceSeries LLC Ltd. Liberal reaction and cooperation was received from the Editorial Board Members of  Associated Journals, Vascular Dementia 2019 Organizing Committee Members and researchers, analysts and pioneers in Dementia, and Vascular Dementia.

The conference was initiated by the Keynote speeches and we are happy to thank all our Keynote Speakers, Honorable Guests, Eminent Speakers and all other attendees for executing such a successful congress.

The conference has encrusted through the following sessions:

Vascular Dementia and Stroke

Causes and Prevention

Vascular Cognitive Impairment

Dementia: Risk Factors

Prevention of Dementia

Dementia Stages

Ageing and Dementia

Advances in Dementia Diagnosis

Dementia Care Management

Dementia Nursing

Neuropharmacology

Novel Therapeutics

Treating Dementia

Neurodegenerative Disorders

We would like to individually thank our Keynote Speakers who participated enthusiastically and very actively:

Hans von, Karolinska University Hospital, Sweden

Anne L. Foundas, Brain Institute of Louisiana, USA

Brian Norris, Founder, Executive Director Living Memories C.I.C.UK

Shu G. Chen, USA Case Western Reserve University School of Medicine, USA

Nancy D. Broz, Rowan University, USA

Kyaien O. Conner, University of South Florida, USA

Morejoy Saineti, Greenwich University London, UK

Amarnath Mallik, Consultant Psychiatrist, India

Taheri Saeid, Byrd Alzheimers Institute, USA

David Truswell, Dementia Alliance for Culture and Ethnicity, UK

Jacqueline A Hinds, Society of Emotional Intelligence UK

Workshop:

Olessia Gorkovenko,Oulos, UNISA, South Africa

The speakers delivered their productive commitment as exceptionally enhancing presentations and made the congress an extraordinary achievement.

We thank all the participants who supported the conference directly by encouraging the healthy discussions among them. Vascular Dementia 2019 expresses gratitude to all the Organizing Committee Members for their extravagant response, support and help. 

After the enormous idealistic reaction from logical crowd, prestigious identities and the Editorial Board Members we are pleased to announce our forth coming conference European Meeting on Dementia, Alzheimer's and Neurological Disorders to be held in Zagreb | Croatia, during May 07-08, 2020.

Let us meet again @ Euro Dementia 2020


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 7-8, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Brain Disorders & Therapy Journal of Neurological Disorders

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Agnosia
  • Alzheimer's Disease
  • Anomia
  • Antidepressants
  • Anxiety
  • Apathy
  • Aphasia
  • Apo E
  • Apraxia
  • Art Therapy
  • Cardiovascular Risk Factors
  • CentralNervous System
  • Cholinesterase Inhibitors
  • Concussions
  • Confusion And Disorientation
  • Cortical Dementia
  • Creutzfeldt-Jakob Disease
  • Deficits
  • Degenerative Neurological Diseases
  • Delusion
  • Dementia With Lewy Bodies
  • Down Syndrome
  • Durable Power Of Attorney
  • Dysarthria
  • Dysphasia
  • Electroencephalogram
  • Frontal Lobe
  • Frontotemporal Dementia
  • Gait
  • Hallucinations
  • Huntington's Disease
  • Hydrocephalus
  • Increased Agitation
  • Korsakoffs Syndrome
  • Memory Loss
  • Meningitis
  • Mini-Mental State Examination
  • Mixed Dementia
  • Neurocognitive Disorders
  • Neurologist
  • Neuropsychologist
  • Occipital Lobe
  • Occupational Therapy
  • Paranoia
  • Parkinson's Disease
  • Pneumonia
  • Positron Emission Tomography
  • Psychiatric Evaluation
  • Repetitive Behavior
  • Sclerosis
  • SPECT
  • Subcortical Dementia
  • SubduralHematomas
  • Suicide Prevention
  • Sundowning
  • Suspiciousness
  • Tau
  • TraumaticBrainInjuries
  • Vascular Dementia
  • Wernicke-Korsakoff Syndrome